BMS-986504 demonstrates sturdy responses in MTAP-deleted NSCLC, together with EGFR and ALK-positive tumors
Credit score: CC0 Public Area BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine…
Ivonescimab + chemotherapy improves progression-free survival in sufferers with EGFR+ NSCLC
Credit score: Anna Tarazevich from Pexels Including ivonescimab, a first-in-class bispecific antibody…
